Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Efron

A/Prof Daryl Efron

Autism Spectrum Disorder in Children

Dr Sonia Davison

Dr Sonia Davison

Early Menopause

Scientia Prof Henry Brodaty AO

Scientia Prof Henry Brodaty AO

Donanemab – A GP Guide to Anti-Amyloid Therapies

Prof Andrew Sindone

Prof Andrew Sindone

LDL and Cardiovascular Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023